Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Cellectricon, a provider of automated screening solutions for drug discovery, has announced its collaboration with Harvard Medical School, the ICCB-Longwood screening facility.
Subscribe to our email newsletter
Under this collaboration, Harvard Medical School (ICCB-L) will utilize the CellaxessHT system, a high throughput transfection enabling reagent-free delivery system, for genome-wide RNAi delivery to biologically relevant cell types.
Jonas Ohlsson, CEO of Cellectricon, said: “Cellectricon is extremely proud to collaborate with a research institution such as Harvard Medical School. We look forward to jointly advance the RNAi research area by our technology, as we’re confident that CellaxessHT will aid in the generation of more relevant results from RNAi screening campaigns.”